Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
43.53
-0.52 (-1.18%)
May 6, 2025, 10:17 AM EDT - Market open
Guardant Health (GH) Revenue by Segment
History
| Date | Development Services | Precision Oncology Testing |
|---|---|---|
| Mar 31, 2025 | - | - |
| Dec 31, 2024 | 51.08M | 687.94M |
| Sep 30, 2024 | 46.72M | 645.54M |
| Jun 30, 2024 | 45.45M | 598.36M |
| Mar 31, 2024 | 46.64M | 557.09M |
| Dec 31, 2023 | 49.70M | 514.25M |
| Sep 30, 2023 | 49.93M | 485.86M |
| Jun 30, 2023 | 55.67M | 454.49M |
| Mar 31, 2023 | 60.85M | 421.31M |
| Dec 31, 2022 | 57.49M | 392.05M |
| Sep 30, 2022 | 63.80M | 366.96M |
| Jun 30, 2022 | 63.95M | 344.18M |
| Mar 31, 2022 | 66.37M | 324.72M |
| Dec 31, 2021 | 69.34M | 304.31M |
| Sep 30, 2021 | 63.55M | 280.31M |
| Jun 30, 2021 | 62.23M | 261.42M |
| Mar 31, 2021 | 58.08M | 239.81M |
| Dec 31, 2020 | 50.41M | 236.32M |
| Sep 30, 2020 | 42.28M | 229.04M |
| Jun 30, 2020 | 36.79M | 220.80M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.